title: Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder.
authors.affiliation: Dept. of Urology, University of Amsterdam, The Netherlands.
authors.forename: K H
authors.initials: KH
authors.lastname: Kurth
authors.forename: K
authors.initials: K
authors.lastname: Mross
authors.forename: F
authors.initials: F
authors.lastname: ten Kate
authors.forename: G
authors.initials: G
authors.lastname: Weissglas
authors.forename: P J
authors.initials: PJ
authors.lastname: Carpentier
authors.forename: C G
authors.initials: CG
authors.lastname: Krueger
authors.forename: J
authors.initials: J
authors.lastname: Blom
authors.forename: J M
authors.initials: JM
authors.lastname: Groen
authors.forename: R D
authors.initials: RD
authors.lastname: van Caubergh
authors.forename: O
authors.initials: O
authors.lastname: van Aubel
mesh_terms: D000283:Administration, Intravesical; D001706:Biopsy; D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D015251:Epirubicin